APOBEC3B and breast carcinoma: Based in part on its expression in breast cancer-derived cell lines and tumors, one group of investigators concluded that A3B is the source of mutations in breast cancer cells 35 but subsequent studies showed that while A3B is overexpressed in many tumor cells18,35,36, it is generally bound to RNA, which largely inactivates it18,37.